ATLANTA, Aug. 4, 2016 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it will participate in the upcoming 36th Annual Canaccord Genuity Annual Growth Conference on Wednesday, August 10, 2016 in Boston, MA.
A live webcast of the Company's presentation is scheduled to begin at 12:30 p.m. ET and will feature an overview of the company and fireside chat with Pat Mackin, Chairman, President and Chief Executive Officer.
The live webcast can be accessed through CryoLife's website, www.cryolife.com, on the Investor Relations page. An archived copy of the webcast will be available for 90 days on the same website.
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac surgical procedures. CryoLife markets and sells products in more than 80 countries worldwide. For additional information about CryoLife, visit our website, www.cryolife.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cryolife-to-present-at-36th-annual-canaccord-genuity-growth-conference-300309600.html
SOURCE CryoLife, Inc.